Skip to main content

Find Clinical Trials

Home
Conditions
Neurodegenerative Diseases

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,019 public trials 1,762 recruiting studies

Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Completed

Evaluation of Galantamine in the Treatment of Alzheimer's Disease

NCT00000172

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: University of Alabama, Birmingham Birmingham, Alabama, United States

James L. Frey, M.D., Ltd. Scottsdale, Arizona, United States

East Bay Neurology Berkeley, California, United States

University of Southern California Los Angeles, California, United States

View all 55 locations

View Trial Details

Completed

Study of Melatonin: Sleep Problems in Alzheimer's Disease

NCT00000171

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +11 more
Locations: University of Arizona Tucson, Arizona, United States

University of California Irvine Institute for Brain Aging and Dementia Irvine, California, United States

University of California, San Diego La Jolla, California, United States

University of Southern California Los Angeles, California, United States

View all 31 locations

View Trial Details

Terminated

Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas

NCT05130866

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +25 more
Locations: House Institute Los Angeles, California, United States

University of California Los Angeles Los Angeles, California, United States

Children's National Hospital Washington D.C., District of Columbia, United States

University of Florida Gainesville, Florida, United States

View all 15 locations

View Trial Details

Terminated

Augmented Reality Treadmill Training in Patients With Parkinson's Disease

NCT04108741

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Department of Neurology Valens, Canton of St. Gallen, Switzerland

View Trial Details

Suspended

Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS)

NCT07102212

Conditions: Alzheimer Disease, Anxiety Disorders, Behavior, +56 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Withdrawn

Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients.

NCT05931484

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Not specified

View Trial Details

Withdrawn

Safety, Tolerability, and Efficacy of PLX-200 in Patients With CLN3

NCT04637282

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +10 more
Locations: Not specified

View Trial Details

Withdrawn

A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)

NCT07075627

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Bronchial Neoplasms, +21 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Withdrawn

Perceptual Decision Making Under Conditions of Visual Uncertainty

NCT01845883

Conditions: Ataxia, Basal Ganglia Diseases, Brain Diseases, +13 more
Locations: Neuroscience Research Building Los Angeles, California, United States

View Trial Details